Literature DB >> 667280

Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants.

G Delitala, T Meloni, A Masala, S Alagna, L Devilla, R Costa.   

Abstract

We studied the effect of i.v. levodopa, pyridoxine and synthetic somatostatin in 28 normal babies during the first hours of life. Somatostatin caused a decrease in GH levels in all infants; in addition, both levodopa and pyridoxine infection paradoxically suppressed GH secretion in all subjects. It is concluded that in the first hours of life GH secretion can be suppressed by synthetic somatostatin as well as by levodopa and pyridoxine administration.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 667280

Source DB:  PubMed          Journal:  Biomedicine        ISSN： 0300-0893


  3 in total

1.  Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion.

Authors:  Song-Guang Ren; Shlomo Melmed
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

Review 2.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

3.  Absent prolactin (PRL) response to thyrotropin releasing hormone (TRH) and somatostatin (SRIF) in at term fetus.

Authors:  G Robuschi; L d'Amato; M Salvi; E Gardini; M Montermini; E Dall'Aglio; E Borciani; V Fontanesi; A Alboni; A Gnudi
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.